Standards FAQ Details | Joint Commission
Follow us on Twitter Friend us on Facebook Vimeo linkedIn Share with your Friends Print this Page
Sunday 11:45 CST, March 18, 2018

Standards FAQ Details


Medication Labeling – IV Solutions Retrieved From Stock Supply
Publish | January 01, 0001
What are the labeling requirements for stock intravenous(IV) solutions pre-labeled by the product manufacturer?

Plain IV solutions retrieved from a stock supply (e.g. an automated dispensing device, floor stock supply, etc) are technically not ‘individualized medication’. The only requirements for labeling include the name, strength, amount, and expiration date that are already on the manufacturer’s label, so relabeling is not necessary.  ‘Individualized’ means only drugs prepared for a specific patient - not floor stock.

When additives are included, the IV solution container must be labeled with the name, strength and amount of all additives, a revised expiration date and have the date prepared and diluents on the label. Additionally, when preparing individualized medications for multiple patients, the label also includes
the following: 
• The patient’s name
• The location where the medication is to be delivered (e.g. patient room)
• Directions for use and applicable accessory and cautionary instructions (e.g. keep refrigerated, etc.).

The requirements for medication labeling are located in the Medication Management (MM) chapter of the accreditation manual at MM.05.01.09.

The requirements for labeling medication containers used during procedures are located in the National Patient Safety Goal chapter of the accreditation manual at NPSG.03.04.01.


Was this response helpful?

Comments (Optional - For internal use only)
Thank you for your feedback!